The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus Lifesciences Limited announced today it has received final approval from the US Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram. The medication ...

Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...

(Image Credits: Pixabay) Zydus on Wednesday said that a breakthrough ... ANVIMO has established bioequivalence with the reference drug, ensuring quality at a fraction of the cost.

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Zydus Lifesciences on Wednesday (February 26 ... vaccine as per WHO recommended composition,” the Ahmedabad-based drug major said in a statement. “Zydus’s Quadrivalent Inactivated Influenza ...

(Image: Freepik) Nuvama Institutional Equities slashed the target price on Zydus Lifesciences by 16% to Rs 840 from Rs 1,003, maintained its ‘Reduce’ rating on the stock. The pharma major is ...

Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...